Published in PLoS Negl Trop Dis on May 16, 2016
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med (1992) 22.13
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature (2002) 11.79
The regulation of immunity to Leishmania major. Annu Rev Immunol (1995) 8.05
The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol (2002) 6.59
Toll-like receptor signaling pathways. Science (2003) 5.86
Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett (2003) 5.27
A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol (1985) 4.71
Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol (2008) 3.61
Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity (1999) 3.01
Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol (2011) 2.93
Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity (2009) 2.86
Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci U S A (1998) 2.75
Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med (2004) 2.57
Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med (1998) 2.30
CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol (2002) 2.16
Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09
Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J Exp Med (2011) 1.93
TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions. J Immunol (2009) 1.91
Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. J Exp Med (2003) 1.91
Cathepsins are required for Toll-like receptor 9 responses. Biochem Biophys Res Commun (2007) 1.81
Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clin Exp Immunol (2006) 1.78
Accumulation of bromodeoxyuridine-labeled cells in central and peripheral lymphoid organs: minimal estimates of production and turnover rates of mature lymphocytes. Eur J Immunol (1990) 1.74
IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol (2001) 1.73
Neutrophil granulocytes--Trojan horses for Leishmania major and other intracellular microbes? Trends Microbiol (2003) 1.72
Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J Exp Med (2002) 1.64
T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett (2005) 1.58
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med (2002) 1.48
TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur J Immunol (2007) 1.46
The role of the innate immune response in Th1 cell development following Leishmania major infection. J Leukoc Biol (1995) 1.40
Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat Immunol (2004) 1.31
How B cells capture, process and present antigens: a crucial role for cell polarity. Nat Rev Immunol (2013) 1.29
Toll-like receptors and leishmaniasis. Infect Immun (2007) 1.27
Cathepsin B is involved in the trafficking of TNF-alpha-containing vesicles to the plasma membrane in macrophages. J Immunol (2008) 1.20
Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of the invariant chain inovalbumin-immunized mice. Immunology (2000) 1.18
Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. J Immunol (1998) 1.14
Comparative expression profiling of Leishmania: modulation in gene expression between species and in different host genetic backgrounds. PLoS Negl Trop Dis (2009) 1.14
Cytotoxic T lymphocytes from cathepsin B-deficient mice survive normally in vitro and in vivo after encountering and killing target cells. J Biol Chem (2006) 1.13
Toll-like receptors in leishmania infections: guardians or promoters? J Parasitol Res (2012) 1.03
Cathepsin-dependent apoptosis triggered by supraoptimal activation of T lymphocytes: a possible mechanism of high dose tolerance. J Immunol (2004) 1.01
Lymph node hypertrophy following Leishmania major infection is dependent on TLR9. J Immunol (2011) 1.00
An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection. Eur J Immunol (2008) 0.99
Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis. Biochem Biophys Res Commun (2001) 0.98
Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection. Infect Immun (2013) 0.97
Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion. Blood (2003) 0.96
The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain. Microbes Infect (2004) 0.96
Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection. Microbes Infect (2004) 0.96
Efficient immunity against Leishmania major in the absence of interleukin-6. Infect Immun (1997) 0.96
Distinct protease requirements for antigen presentation in vitro and in vivo. J Immunol (2010) 0.92
Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease. Infect Immun (2001) 0.89
Treatment with cathepsin L inhibitor potentiates Th2-type immune response in Leishmania major-infected BALB/c mice. Int Immunol (2001) 0.85
Keratinocytes determine Th1 immunity during early experimental leishmaniasis. PLoS Pathog (2010) 0.84
CpG inhibits pro-B cell expansion through a cathepsin B-dependent mechanism. J Immunol (2010) 0.83
Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines. J Biol Chem (2015) 0.82
Multiple Cathepsins Promote Pro-IL-1β Synthesis and NLRP3-Mediated IL-1β Activation. J Immunol (2015) 0.81
The IL-6-deficient mouse exhibits impaired lymphocytic responses to a vaccine combining live Leishmania major and CpG oligodeoxynucleotides. Can J Microbiol (2009) 0.79
Cathepsin B in antigen-presenting cells controls mediators of the Th1 immune response during Leishmania major infection. PLoS Negl Trop Dis (2014) 0.79
TLR9 activation is triggered by the excess of stimulatory versus inhibitory motifs present in Trypanosomatidae DNA. PLoS Negl Trop Dis (2014) 0.79
Cathepsin B controls the persistence of memory CD8+ T lymphocytes. J Immunol (2012) 0.77
TLR9 activation is triggered by the excess of stimulatory versus inhibitory motifs present in Trypanosomatidae DNA. PLoS Negl Trop Dis (2014) 0.79